REGN profile · all as-reported value updates
REGENERON PHARMACEUTICALS, INC. (REGN) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2018 | 6,710,800,000 | 5,145,600,000 | -1,565,200,000 | -23.32% | revised comparative figure | 0001532176-19-000009 0001804220-21-000008 | 3 filed observations examined for this concept and period. |
| Revenue | 2019 | 7,863,400,000 | 6,557,600,000 | -1,305,800,000 | -16.61% | revised comparative figure | 0001532176-20-000008 0001804220-22-000007 | 3 filed observations examined for this concept and period. |